Neuro-Oncology Reviews
Volume
25 Number 13
15 July 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 13, 15 July
Czarnywojtek A, Gut P, Borowska M,
Dyrka K, Ruchała M, Ferlito A.
A
new hypothesis
in the treatment of recurrent glioblastoma multiforme (GBM). Part
1: Introduction.
Pol
Merkur Lekarski. 2023 Jul;51(4):430-432∟.
doi: 10.36740/Merkur202304119∟.
PMID: 37756465∟.
Perspective. ˍ
*
Eckerdt F, Platanias LC.
Emerging Role
of Glioma Stem Cells in Mechanisms of Therapy Resistance.
Cancers
(Basel). 2023 Jul 1;15(13):3458∟.
doi: 10.3390/cancers15133458∟.
PMID: 37444568∟.
Review. ˍ
Damodharan S, Abbott A, Kellar K, Zhao Q, Dey M.
Molecular
Characterization and Treatment Approaches for Pediatric H3
K27-Altered Diffuse Midline
Glioma: Integrated Systematic Review of Individual Clinical Trial
Participant Data.
Cancers
(Basel). 2023 Jul 3;15(13):3478∟.
doi: 10.3390/cancers15133478∟.
PMID: 37444588∟.
Review. ˍ
Halatsch ME.
Special Issue: Principal
Challenges in the Adjuvant Treatment of
Glioblastoma.
Biomedicines. 2023 Jul 3;11(7):1881∟.
doi: 10.3390/biomedicines11071881∟.
PMID: 37509520∟.
Editorial. ˍ
Kringel R, Lamszus K, Mohme M.
Chimeric
Antigen Receptor T Cells in Glioblastoma-Current Concepts and
Promising Future.
Cells.
2023 Jul 3;12(13):1770∟.
doi: 10.3390/cells12131770∟.
PMID: 37443804∟.
Review. ˍ
Leskinen S, Shah HA, Yaffe B, Schneider SJ, Ben-Shalom N, Boockvar
JA, D'Amico RS, Wernicke AG.
Hippocampal
avoidance in whole brain radiotherapy and prophylactic cranial
irradiation: a systematic review and meta-analysis.
J
Neurooncol. 2023 Jul 3∟.
doi: 10.1007/s11060-023-04384-6∟.
PMID: 37395975∟.
Review, Meta-analysis˰ ˍ
Li Y, Fang B.
Neural stem cell-derived
extracellular vesicles: The light of central nervous system
diseases.
Biomed
Pharmacother. 2023 Jul 3;165:115092∟.
doi: 10.1016/j.biopha.2023.115092∟.
PMID: 37406512∟.
Review. ˍ
Yang Y, Cheng N, Luo Q, Shao N, Ma X, Chen J, Luo L, Xiao Z.
How
Nanotherapeutic Platforms Play a Key Role in Glioma? A
Comprehensive Review of Literature.
Int
J Nanomedicine. 2023 Jul 3;18:3663-3694∟.
doi: 10.2147/IJN.S414736∟.
PMID: 37427368∟.
Review. ˍ
*
Cho NS, Wong WK, Nghiemphu PL, Cloughesy TF, Ellingson BM.
The
Future Glioblastoma Clinical Trials Landscape: Early Phase 0,
Window of Opportunity, and Adaptive Phase I-III Studies.
Curr
Oncol Rep. 2023 Jul 4∟.
doi: 10.1007/s11912-023-01433-1∟.
PMID: 37402043∟.
Review. ˍ
Wu Y, Qian Y, Peng W, Qi X.
Functionalized
nanoparticles crossing the brain-blood barrier to target glioma
cells.
PeerJ. 2023 Jul
4;11:e15571∟.
doi: 10.7717/peerj.15571∟.
PMID: 37426416∟.
Review. ˍ
Yang J, He Z, Li M, Hong T, Ouyang T.
Risk
of intracranial hemorrhage with direct oral anticoagulation versus
low molecular weight heparin in the treatment of brain
tumor-associated venous thromboembolism: A meta-analysis.
J
Stroke Cerebrovasc Dis. 2023 Jul 4;32(8):107243∟.
doi: 10.1016/j.jstrokecerebrovasdis.2023.107243∟.
PMID: 37413715∟.
Meta-analysis˰ ˍ
Rodriguez SMB, Kamel A, Ciubotaru GV, Onose G, Sevastre AS,
Sfredel V, Danoiu S, Dricu A, Tataranu LG.
An
Overview of EGFR Mechanisms and Their Implications in Targeted
Therapies for Glioblastoma.
Int
J Mol Sci. 2023 Jul 5;24(13):11110∟.
doi: 10.3390/ijms241311110∟.
PMID: 37446288∟.
Review. ˍ
Guo B, Zhang S, Xu L, Sun J, Chan WL, Zheng P, Zhang J, Zhang
L.
Efficacy and safety of innate and
adaptive immunotherapy combined with standard of care in
high-grade gliomas: a systematic review and meta-analysis.
Front
Immunol. 2023 Jul 6;14:966696∟.
doi: 10.3389/fimmu.2023.966696∟.
PMID: 37483593∟.
Review, Meta-analysis. ˍ
Louis DN.
A vade mecum for crossing the
second translational "valley of death" in brain tumor
classification.
Brain
Pathol. 2023 Jul 6:e13183∟.
doi: 10.1111/bpa.13183∟.
PMID: 37409518∟.
Perspective.
ˍ
Mukherjee T, Pournik O, Lim Choi Keung SN, Arvanitis TN.
Clinical
Decision Support Systems for Brain Tumour Diagnosis and Prognosis:
A Systematic Review.
Cancers
(Basel). 2023 Jul 6;15(13):3523∟.
doi: 10.3390/cancers15133523∟.
PMID: 37444633∟.
Review. ˍ
Woods RR, Lesser GJ.
Management of
Thromboembolic Disease in Patients with Primary and Metastatic
Brain Tumors.
Curr
Treat Options Oncol. 2023 Jul 6∟.
doi: 10.1007/s11864-023-01116-w∟.
PMID: 37407888∟.
Review. ˍ
Bernstock JD, Blitz SE, Hoffman SE, Gerstl JVE, Chiocca EA,
Friedman GK.
Recent oncolytic
virotherapy clinical trials outline a roadmap for the treatment of
high-grade glioma.
Neurooncol
Adv. 2023 Jul 7;5(1):vdad081∟.
doi: 10.1093/noajnl/vdad081∟.
PMID: 37497017∟.
Review. ˍ
*
Sabahi M, Salehipour A, Bazl MSY, Rezaei N, Mansouri A,
Borghei-Razavi H.
Local immunotherapy
of glioblastoma: A comprehensive review of the concept.
J
Neuroimmunol. 2023 Jul 7;381:578146∟.
doi: 10.1016/j.jneuroim.2023.578146∟.
PMID: 37451079∟.
Review˰ ˍ
Hu X, Jiang C, Gao Y, Xue X.
Human
dendritic cell subsets in the glioblastoma-associated
microenvironment.
J
Neuroimmunol. 2023 Jul 10;383:578147∟.
doi: 10.1016/j.jneuroim.2023.578147∟.
PMID: 37643497∟.
Review˰ ˍ
Bai H, Jiang C.
Editorial: Advances in
surgical approaches for the treatment of glioma.
Front
Oncol. 2023 Jul 11;13:1236341∟.
doi: 10.3389/fonc.2023.1236341∟.
PMID: 37496655∟.
Editorial. ˍ
Cedergren Weber G, Timpka J, Rydelius A, Bengzon J, Odin
P.
Tumoral parkinsonism-Parkinsonism
secondary to brain tumors, paraneoplastic syndromes, intracranial
malformations, or oncological intervention, and the effect of
dopaminergic treatment.
Brain
Behav. 2023 Jul 11:e3151∟.
doi: 10.1002/brb3.3151∟.
PMID: 37433071∟.
Review. ˍ
Erkan B, Demir S, Akpinar E, Akkurt TS, Tanriverdi O, Gunaldi O.
A
rare tumor in the sellar region: ganglioglioma, a case report and
a general overview.
Childs
Nerv Syst. 2023 Jul 11∟.
doi: 10.1007/s00381-023-06073-1∟.
PMID: 37432397∟.
Case report, Review˰ ˍ
Nowak I, Madej M, Secemska J, Sarna R, Strzalka-Mrozik
B.
Virus-Based Biological Systems as
Next-Generation Carriers for the Therapy of Central Nervous System
Diseases.
Pharmaceutics.
2023 Jul 11;15(7):1931∟.
doi: 10.3390/pharmaceutics15071931∟.
PMID: 37514117∟.
Review. ˍ
Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI.
Wants
and needs for involvement reported by relatives of patients with a
malignant brain tumour: a scoping review.
JBI
Evid Synth. 2023 Jul 12∟.
doi: 10.11124/JBIES-22-00311∟.
PMID: 37435678∟.
Review˰ ˍ
Langen KJ, Galldiks N, Mauler J, Kocher M, Filß CP, Stoffels
G, Régio Brambilla C, Stegmayr C, Willuweit A, Worthoff WA,
Shah NJ, Lerche C, Mottaghy FM, Lohmann P.
Hybrid
PET/MRI in Cerebral Glioma: Current Status and
Perspectives.
Cancers
(Basel). 2023 Jul 12;15(14):3577∟.
doi: 10.3390/cancers15143577∟.
PMID: 37509252∟.
Review. ˍ
Wu O, Clift GW, Hilliard S, Ip M.
Evaluating
the use of intraoperative magnetic resonance imaging in paediatric
brain tumour resection surgeries: a literature review.
J
Med Radiat Sci. 2023 Jul 12∟.
doi: 10.1002/jmrs.707∟.
PMID: 37434551∟.
Review. ˍ
Aziz PA, Memon SF, Hussain M, Memon AR, Abbas K, Qazi SU, Memon
RAR, Qambrani KA, Taj O, Ghazanfar S, Ellahi A, Ahmed
M.
Supratotal Resection - An Emerging
Concept Of Gliomablastoma Multiforme Surgery - Systematic Review
And Meta-Analysis.
World
Neurosurg. 2023 Jul 13:S1878-8750(23)00950-6∟.
doi: 10.1016/j.wneu.2023.07.020∟.
PMID: 37451363∟.
Review, Meta-analysis˰ ˍ
Gupta T, Selvarajan JMP, Kannan S,
Menon N, Dasgupta A, Chatterjee A.
Updated
systematic review and meta-analysis of extended adjuvant
temozolomide in patients with newly diagnosed
glioblastoma.
Neurooncol
Adv. 2023 Jul 13;5(1):vdad086∟.
doi: 10.1093/noajnl/vdad086∟.
PMID: 37638346∟.
Review. ˍ
McDougall E, Breen LJ, Nowak AK,
Dhillon HM, Halkett GKB.
Psychosocial
interventions
for personality and behavior changes in adults with a brain tumor:
A
scoping review.
Neurooncol
Pract. 2023 Jun 13;10(5):408-417∟.
doi: 10.1093/nop/npad031∟.
PMID: 37720389∟.
Review˰ ˍ
Zhang L, Dimberg A, Rasouli J.
Editorial:
The blood-brain barrier in brain tumors: molecular mechanisms and
therapeutic strategies.
Front
Neurol. 2023 Jul 13;14:1225594∟.
doi: 10.3389/fneur.2023.1225594∟.
PMID: 37521282∟.
Editorial. ˍ
Hsu TI.
Editorial: Metabolic
reprogramming for acquiring therapeutic resistance in
glioblastoma.
Front
Oncol. 2023 Jul 14;13:1220063∟.
doi: 10.3389/fonc.2023.1220063∟.
PMID: 37519794∟.
Editorial. ˍ
Jia H, Zhang H, Miao F, Lu D, Wang X, Gong L, Fan Y.
CSF
Biopsy in Glioma: A Brief Review.
Methods
Mol Biol. 2023 Jul 15;2695:121-126∟.
doi: 10.1007/978-1-0716-3346-5_8∟.
PMID: 37450115∟.
Review˰ ˍ
Krajcer A, Grzywna E, Lewandowska-Łańcucka J.
Strategies
increasing the effectiveness of temozolomide at various levels of
anti-GBL therapy.
Biomed
Pharmacother. 2023 Jul 15;165:115174∟.
doi: 10.1016/j.biopha.2023.115174∟.
PMID: 37459661∟.
Review. ˍ
Mehta NH, Shah HA, D'Amico RS.
Sonodynamic
Therapy and Sonosensitizers for Glioma Treatment: A Systematic
Qualitative Review.
World
Neurosurg. 2023 Jul 15:S1878-8750(23)00961-0∟.
doi: 10.1016/j.wneu.2023.07.030∟.
PMID: 37454909∟.
Review˰ ˍ
Nguyen AV, Soto JM, Gonzalez SM, Murillo J, Trumble ER, Shan FY,
Huang JH.
H3G34-Mutant Gliomas-A Review
of Molecular Pathogenesis and Therapeutic Options.
Biomedicines.
2023 Jul 15;11(7):2002∟.
doi: 10.3390/biomedicines11072002∟.
PMID: 37509641∟.
Review. ˍ